Clinical Trial Update: SMV + SOF With/Without RBV for IFN-II Patients With CHC [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of simeprevir and sofosbuvir, with or without ribavirin, in interferon-experienced chronic hepatitis C patients; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: SC Liver Research Consortium, LLC | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2018-05-17